Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 10 days ago
Share
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
145 patients around the world
Available in
Mexico
Pfizer
145
Patients around the world
Requirements for the patient
To 74 Years
Male
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Sponsor
Pfizer
Study type
Interventional
Requirements
To 74 Years
Male
Unique study ID
clinicaltrials.gov
NCT05145127
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent